The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation

Transplant Immunology

Volumn 16, Issue 3-4, 2006, Pages 258-262

  Alakulppi, Noora S ^a   Kyllönen, Lauri E ^b   Salo, Hanna M E ^a   Partanen, Jukka ^a   Salmela, Kaija T ^b   Laine, Jarmo T ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cytomegalovirus; Interleukin 10; Kidney transplantation; Polymorphism

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ARTICLE; CADAVER DONOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTIVITY;

ADOLESCENT; ADULT; AGED; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INCIDENCE; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33751344163     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.007     Document Type: Article

References (19)

1. Nett P.C., Heisey D.M., Fernandez L.A., Sollinger H.W., and Pirsch J.D. Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. Transplantation 78 7 (2004) 1036-1041
2. Hurme M., and Helminen M. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand J Infect Dis 30 5 (1998) 447-449
3. Hurme M., Haanpaa M., Nurmikko T., Wang X.Y., Virta M., Pessi T., et al. IL-10 gene polymorphism and herpes virus infections. J Med Virol 70 Suppl 1 (2003) S48-S50
4. Suarez A., Castro P., Alonso R., Mozo L., and Gutierrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75 5 (2003) 711-717
5. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 1 (1997) 1-8
6. Essa S., Raghupathy R., Pacsa A.S., el Shazly A., Said T., and Azizieh F. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J Med Virol 60 2 (2000) 223-229
7. Tong C.Y., Bakran A., Williams H., Cuevas L.E., Peiris J.S., and Hart C.A. Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 64 1 (2001) 29-34
8. Perrey C., Pravica V., Sinnott P.J., and Hutchinson I.V. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol 6 3 (1998) 193-197
9. Conti P., Kempuraj D., Kandere K., Gioacchino M.D., Barbacane R.C., Castellani M.L., et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 86 2 (2003) 123-129
10. Spencer J.V., Lockridge K.M., Barry P.A., Lin G., Tsang M., Penfold M.E., et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76 3 (2002) 1285-1292
11. Kotenko S.V., Saccani S., Izotova L.S., Mirochnitchenko O.V., and Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97 4 (2000) 1695-1700
12. Geist L.J., and Hinde S.L. Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus. J Investig Med 49 5 (2001) 434-441
13. Biron C.A. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6 4 (1994) 530-538
14. Tornatore K.M., Garey K.W., Saigal N., Reed K., Murray B., Ingalls E., et al. Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant 15 5 (2001) 297-308
15. Redpath S., Angulo A., Gascoigne N.R., and Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162 11 (1999) 6701-6707
16. Sissons J.G., Carmichael A.J., McKinney N., Sinclair J.H., and Wills M.R. Human cytomegalovirus and immunopathology. Springer Semin Immunopathol 24 2 (2002) 169-185
17. Hariharan S. Case 5: new clinical trials in renal transplantation. Transplantation 76 8 (2003) 1270-1274
18. Sola R., Alarcon A., Jimenez C., and Osuna A. The influence of delayed graft function. Nephrol Dial Transplant 19 Suppl 3 (2004) iii32-iii37
19. Hodson E.M., Jones C.A., Webster A.C., Strippoli G.F., Barclay P.G., Kable K., et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 365 9477 (2005) 2105-2115